Concepedia
Statistics
Publications
7
Citations
575
H-Index
Active since
2014
Affiliations
Memorial Sloan Kettering Cancer Center(Current)
The University of Texas MD Anderson Cancer Center
Janssen (United States)
University of Maryland, Baltimore
Massachusetts General Hospital
Irina Kline is an author at Memorial Sloan Kettering Cancer Center specializing in pathology, medicine, and pharmacotherapy.
Top concepts
HealthMedicineOncologyPathologyCancer ResearchPharmacotherapyGeneticsRadiologyHematologyPharmacology
Publications per year
2014–2023
Differentiation Syndrome Associated With Enasidenib, a Selective Inhibitor of Mutant Isocitrate Dehydrogenase 2
Amir T. Fathi, Courtney D. DiNardo, Irina Kline et al. · JAMA Oncology · 2018 · 191 citations · Full text
Effect of Canagliflozin on Blood Pressure and Adverse Events Related to Osmotic Diuresis and Reduced Intravascular Volume in Patients With Type 2 Diabetes Mellitus
Matthew R. Weir, Andrzej Januszewicz, Richard E. Gilbert et al. · Journal of Clinical Hypertension · 2014 · 118 citations · Full text
Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes and Stage 3 Nephropathy
Hala Yamout, Vlado Perkovic, Melanie J. Davies et al. · American Journal of Nephrology · 2014 · 116 citations · Full text
Safety and Tolerability of Canagliflozin in Patients With Type 2 Diabetes Mellitus: Pooled Analysis of Phase 3 Study Results
Keith Usiskin, Irina Kline, Albert Fung et al. · Postgraduate Medicine · 2014 · 95 citations
Safety and efficacy of the novel BRAF inhibitor FORE8394 in patients with advanced solid and CNS tumors: Results from a phase 1/2a study.
Macarena I. de la Fuente, Jordi Rodón, Rona Yaeger et al. · Journal of Clinical Oncology · 2023 · 24 citations
Pathology, Phase 1/2A, Pharmacotherapy +17
1–5 of 7